Surgical removal of peripapillary choroidal neovascularization associated with age-related macular degeneration

Ophthalmic Surgery Lasers and Imaging

Volumn 36, Issue 5, 2005, Pages 358-364

  Blinder, Kevin J ^a,c   Shah, Gaurav K ^a   Thomas, Matthew A ^a   Holekamp, Nancy M ^a   Joseph, Daniel P ^a   Grand, M Gilbert ^a   Sharma, Sanjay ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c BARNES RETINA INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CATARACT; CLINICAL ARTICLE; DISEASE ASSOCIATION; EYE SURGERY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; LASER COAGULATION; MALE; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; REVIEW; SUBRETINAL NEOVASCULARIZATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 26244443679     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/1542-8877-20050901-03     Document Type: Review

References (12)

1. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP Report I. Arch Ophthalmol. 1999;117:1329-1345.
2. Bresslar NM, Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials. TAP Report 2. Arch Ophthalmol. 2001;119:198-207.
3. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy: five-year results from randomized clinical trials. Arch Ophthalmol. 1991;109:1109-1114.
4. Macular Photocoagulation Study Group. Laser photocoagulation for neovascular lesions nasal to the fovea: results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol. 1995;113:56-61.
5. Turcotte P, Maguire MG, Fine SL. Visual results after laser treatment for peripapillary choroidal neovascular membranes. Retina. 1991;11:295-300.
6. Thomas MA, Kaplan HJ. Surgical removal of subfoveal neovascularization in the presumed ocular histoplasmosis syndrome. Am J Ophthalmol. 1991;111:1-7.
7. Blinder KJ, Peyman GA, Paris CL, Gremillion CM Jr. Submacular scar excision in age-related macular degeneration. Int Ophthalmol. 1991;15:215-222.
8. Atebara NH, Thomas MA, Holekamp NM, Mandell BA, Del Priore LV. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Ophthalmology. 1998;105:1598-1605.
9. Rosenblatt BJ, Shah GK, Blinder KJ. Photodynamic therapy with verteporfin for peripapillary choroidal neovascularization. Retina. 2005;25:33-37.
10. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med. 2004;351:2805-2816.
11. Gass JDM. Biomicroscopic and histopathologic considerations regarding the feasibility of surgical excision of subfoveal neovascular membranes. Am J Ophthalmol. 1994;118:285-298.
12. Grossniklaus HE, Gass JDM. Clinicopathologic correlations of surgically excised type 1 and type 2 submacular choroidal neovascular membranes. Am J Ophthalmol. 1998;126:59-69.